|Ms. Susan Channon||CEO, MD & Director||637.45k||N/A||1957|
|Mr. Glenn Powers||CFO & Company Sec.||526.87k||N/A||1960|
|Mr. Steve Zappia||MD of Queensland & MD of Virtus Health Diagnostics||313.97k||N/A||1959|
|Ms. Nadia Stankovic||Managing Director of New South Wales||252.87k||N/A||N/A|
|Ms. Jade Phelan||Managing Director of Victoria||324.68k||N/A||N/A|
Virtus Health Limited provides various healthcare services in New South Wales, Queensland, Victoria, Tasmania, Denmark, the United Kingdom, Ireland, and Singapore. It provides fertility care and related specialized diagnostics, as well as day hospital services. The company offers in-vitro fertilization (IVF) services, including ovulation induction, intrauterine insemination, introcytoplasmic injection, GIFT, blastocyst culture, frozen embryo transfer, egg and semen freezing and storage, testicular biopsy, and support and counseling services, as well as donor egg, embryo, and sperm services. It also provides endocrinology, andrology, preimplantation genetic, and cytogenetic diagnostic services; and gynecological and obstetric ultrasound scanning and procedures. In addition, the company offers day hospital procedures, such as IVF, endoscopy, gynaecology, urology, dental, ophthalmic, cosmetic surgery, and plastic surgery. As of August 21, 2018, it operated through a network of 126 fertility specialists. The company was founded in 2008 and is headquartered in Greenwich, Australia.
Virtus Health Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.